United Health Products Issues FDA Submission Update

Henderson, Nevada – October 10, 2017 – United Health Products, Inc. (OTCQB: UEEC) a manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that its current Expanded Indication Submission Class II application for HemoStyp for internal usage with the U.S. FDA continues to progress, and is in an advanced stage of review.  In addition, the company is pleased to announce that it has applied to the FDA’s new and innovative CtQ Pilot Program premarket approval PMA (Class III internal usage) for HemoStyp.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years of prior product usage and studies—to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safe interaction to enter the market in a more efficient manner.  This application will run simultaneously with the company’s prior Class II application for expanded indication. The market for 2017 for internal surgical hemostatic products is estimated to be more than seven billion, and is expected to grow at 7.1% over the next few years, to reach more than $8.3 billion by 2022.
(http://industryarc.com/Report/15189/hemostats-market.html)  

About United Health Products Inc. 
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

For further information contact Investor Relations:
Philippe Niemetz
PAN Consultants Ltd.
212-344-6464
p.niemetz@panconsultants.com

 

United Health Products and Patterson/Animal Health International Launch Nationwide Marketing Campaign for HemoStyp® Products to U.S. Veterinary Healthcare Market

Henderson, Nevada – August 28, 2017 – United Health Products, Inc. (OTCQB: UEEC) a manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that, in conjunction with Patterson Veterinary/Animal Health International, Inc. (AHI), a subsidiary of Patterson Companies, Inc., it will conduct a marketing campaign to more than 8,000 companion animal clinics in the United States. 

Patterson Veterinary/AHI, United Health Products’ exclusive distributor to the U.S. animal health market, with a sales force more than 400 strong, will officially launch the campaign on September 1, which will last until year end 2017.  The campaign’s objective is to significantly increase sales of four HemoStyp products to the $10 Billion domestic veterinary healthcare market, and to attain  major market share gains in that market, one of the five that United Health Products serves.

 "We expect the marketing campaign with Patterson Veterinary/AHI to lead to significant sales in the third and fourth quarter of this year,” said Douglas K. Beplate, CEO. “Patterson Veterinary/AHI is one of the largest animal health companies in the United States, and we have been working diligently with them to make this program a success. Additional incentives to customers, coupled with our already leading cost effective pricing, should enable us to expand our footprint in this rapidly growing market. “ 

About Patterson Veterinary/Animal Health International
Patterson Veterinary/Animal Health International, Inc. is the premier animal health company in North America and has been serving the needs of customers for more than 40 years. No other distributor has a broader product offering. Patterson Veterinary/Animal Health International represents over 1,000 manufacturers that supply products focused on companion animal, equine, beef and dairy cattle, poultry, and swine. Patterson Veterinary/Animal Health International offers products ranging from vaccines and pharmaceuticals to state of the art equipment and software. Patterson Companies acquired Animal Health International in May of 2016 to become one of the largest Veterinary suppliers in the country.

About United Health Products Inc. 
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

For further information contact Investor Relations:
Philippe Niemetz
212-344-6464 ● PAN Consultants Ltd. 
p.niemetz@panconsultants.com 



United Health Products Inc. To File Late 2016 Audited Year End

Henderson, NV -  April 18, 2017 - United Health Products, Inc. (OTCQB: UEEC) announced that revenues for the fourth quarter of 2016 were approximately $252,000 and that the company is expecting to see increasing quarterly revenues for 2017. The company’s independent registered public accountants, Pritchett Siler & Hardy, P.C., are in the process of auditing 2016 financial statements and will present to the prior auditors RRBB for their opinion and approval. A late filing of our Form 10-K for the fiscal year ended December 31, 2016 is anticipated within the next two weeks. Douglas Beplate, CEO of UHP, commented that this is a major step forward for the company to have an auditing firm recognized in the auditing of public posted companies performing the audits as we move forward in creating market awareness and value.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. To Host Dial in Corporate Update

Henderson, NV -  March 31, 2017 - United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on Tuesday, April 4, 2017 at 12:30 PM Eastern Time. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss present business, marketing plans for 2017, and future events for 2017. To listen to the discussion:

Participant Instructions: 

1.  Call your Dial-In Number: (712) 451-0011 
2.  Enter your Access Code: 291859.

Anyone not able to access or attend the call can go to the company’s website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Wednesday, April 5, by noon EST.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. To Host Dial in Corporate Update

Henderson, NV -  March 31, 2017 - United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on Tuesday, April 4, 2017 at 12:30 PM Eastern Time. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss present business, marketing plans for 2017, and future events for 2017. To listen to the discussion:

Participant Instructions: 

1.  Call your Dial-In Number: (712) 451-0011 
2.  Enter your Access Code: 291859.

Anyone not able to access or attend the call can go to the company’s website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Wednesday, April 5, by noon EST.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. To Host Dial in Corporate Update

Henderson, NV -  January 12, 2017 - United Health Products, Inc. (OTCQB: UEEC) will hold a dial-in conference for shareholders, potential shareholders and those seeking to learn more about the company on Tuesday January 17, 2017 at 12:30 PM Eastern Time. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss year end 2016, present business and current rollout to the veterinary market, marketing plans for 2017 and future events for 2017. To listen to the discussion:

Participant Instructions: 

1.  Call your Dial-In Number: (712) 451-0011 
2.  Enter your Access Code: 291859.

Anyone not able to access or attend the call can go to the company’s website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Wednesday, January 18 by noon EST.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


UNITED HEALTH PRODUCTS INC TO HOST DIAL IN CORPORATE UPDATE

Henderson, NV -  October 11, 2016 - United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on October 13, 2016. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss the company’s current events and expansion of manufacturing capacities to meet the increase in current orders in the dental, veterinary, medical and retail markets. Management will also report on the future plans and efforts of the company to uplist to a higher exchange. The call in conference will be Thursday October 13th at 12:30 pm Eastern. To listen to the discussion:

Participant Instructions: 

1.  Call your Dial-In Number: (712) 451-0011 
2.  Enter your Access Code: 291859.

Anyone not able to access or attend the call can go to the company’s website www.unitedhealthproductsinc.com and listen to the entire call which will posted as an audio file on Friday October 14th by noon EST.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Optimal Government Services Has Completed Their Distribution Agreement and Placed Stocking Orders

Henderson, NV -  May 16, 2016 - United Health Products, Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract #SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense (DOD) and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. This customer base includes the DOD, all branches of the military, all federal government offices and programs. Optimal GS specializes in distribution of medical products through this network, utilizing the MSPV bridge contracts. The VA has created a major benefit to our Nation's Veterans by continuing to provide efficient and unparalleled medical supply support to VA medical centers nationwide. The program is mandatory for all VA medical centers. The MSPV program includes McKesson and Cardinal distribution.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

United Health Products Inc. Announces Optimal Government Services Has Completed Their Distribution Agreement and Placed Stocking Orders

Henderson, NV -  May 16, 2016 - United Health Products, Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract #SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense (DOD) and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. This customer base includes the DOD, all branches of the military, all federal government offices and programs. Optimal GS specializes in distribution of medical products through this network, utilizing the MSPV bridge contracts. The VA has created a major benefit to our Nation's Veterans by continuing to provide efficient and unparalleled medical supply support to VA medical centers nationwide. The program is mandatory for all VA medical centers. The MSPV program includes McKesson and Cardinal distribution.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

United Health Products Announces Henry Schein Halas as Exclusive Distributor

Henderson, NV -  May 2, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health’s HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of Henry Schein, the world's leading dental distributor. Their commitment to meeting and exceeding the service expectations of our customers is deeply ingrained in to their organization.  Henry Schein currently supplies over 80% of all dental practices in Australia and New Zealand and has 18 distribution centers in the region. Henry Schein is also the number one supplier in Australia and New Zealand in the Veterinary market. Henry Schein currently supplies more than 70% of the market.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Announces Henry Schein Halas as Exclusive Distributor

Henderson, NV -  May 2, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health’s HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of Henry Schein, the world's leading dental distributor. Their commitment to meeting and exceeding the service expectations of our customers is deeply ingrained in to their organization.  Henry Schein currently supplies over 80% of all dental practices in Australia and New Zealand and has 18 distribution centers in the region. Henry Schein is also the number one supplier in Australia and New Zealand in the Veterinary market. Henry Schein currently supplies more than 70% of the market.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Exclusive Distributor for India

Henderson, NV -  March 9, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into an exclusive distribution contract with CJ Global Capital LLC for India. The exclusive contract has a licensing fee and minimum yearly purchase requirements to maintain the rights to exclusivity to India for all of United Health Products Inc. HemoStyp® products. India's current health care industry is estimated to be USD 120 Billion and reach USD 230 Billion by 2020, with USD 5.5 Billion in Wound Care. Indian Government Expenditure on health care is the highest amongst all the developing countries. The expenses of this industry comprise 5.25% of the GDP. India is the second most populous country in the world, with over 1.277 billion people (2015), more than a sixth of the world's population. 

About CJ Global Capital LLC

CJ Global Capital LLC is a private international investment group headquartered in the United States specializing in projects involving patented products, new technologies, and large scale commercial real estate development. CJGC sales and marketing efforts for wholesaling will be led by David Champion, Marketing Director of Asia Pacific for Apollo RT Co., Ltd. Apollo RT Co. is a new Japanese owned company with manufacturing in China. David Champion is responsible for marketing and strategy for the Asian Market. In addition, David is Country Director for Apollo RT Co. business in Korea and Canada. David lived in India in the late 1990's and was employed by a company which is now part of GE Healthcare. He worked 13 years for Tyco Healthcare (later known as Covidien) in urological products (including incontinence products) and wound care products. CJGC various projects total USD 1 billion.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Announces Optimal Government Services as Exclusive Government Distributor

Henderson, NV -  January 21, 2016 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a contract with Optimal Government Resources as the exclusive government distributor for its HemoStyp® product line.  Douglas Beplate, CEO of United Health Products Inc. added, “We are very pleased to be working with Optimal GS and to provide our HemoStyp® products to the U.S. Military and other U.S. Government agencies”.  The contract outlines the addition of HemoStyp® products to Optimal’s ERP, Service Order Module, included in the existing DAPA MS contract, registered in the Military and DOD Prime Vendor catalogs and assigned number registry with the Prime Vendor.

About Optimal Government Services

Optimal GS is a participant in the Department of Defense and Department of Veterans Affairs Medical/Surgical Prime Vendor Programs (MSPV), and the DOD and VA Pharmaceutical Prime Vendor Program (PPV). Optimal has commercial agreements with the National and Regional Prime Vendors to ensure highly efficient national distribution of its products to its Federal Customer Base. Optimal GS specializes in moving medical product through this network.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. HemoStyp® Now Available From Patterson Veterinary

Henderson, NV -  November 19, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that one of the nation's largest veterinary distribution companies Patterson Veterinary, a leading supplier of health supplies and equipment to veterinarians, has placed their initial stocking order with AMD Ritmed www.amdritmed.com, United Health's Sales and Marketing partner. Patterson Veterinary will be distributing and promoting the HemoStyp® products nationwide. Patterson Veterinary distributes consumable veterinary supplies, equipment, software, diagnostic products, vaccines and pharmaceuticals to veterinary clinics throughout the U.S. and U.K. Douglas Beplate CEO of United Health Products Inc. added, "We are very pleased to be working with Patterson Veterinary to provide HemoStyp® to clinics and Veterinarians across the country. Hemostyp® is the perfect product for providing faster bleeding control in small and large animals".

About Patterson Animal Health

Patterson is a Fortune 1000 member recognized by Forbes as one of America's Most Trusted Companies. Patterson's business presence includes the animal health and dental markets. The Company employs approximately 7,000 team members in North America and the U.K.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. HemoStyp® Now Available Through Henry Schein

Henderson, NV -  August 24, 2015 - United Health Products, Inc. (OTCQB: UEEC)) developer, manufacturer and marketer of patented hemostatic gauze for the dental, healthcare, veterinary and wound care sectors, today announced that Henry Schein, the nation’s largest distributor of dental products,  is now providing HemoStyp® to Dental professionals across the country. Hemostyp® is now available to all dental professionals nationwide through Henry Schein www.henryschein.com and its vast network.

About Henry Schein, Inc

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. For more information, visit the Henry Schein Web site at www.henryschein.com. 

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

 


United Health Products Inc. Announces ‘School Health’ as a Distributor

Henderson, NV -  August 24, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that School Health, the nation's leading supplier of health supplies and equipment to schools, has placed their initial stocking order with UEEC and will be distributing and promoting the HemoStyp® products nationwide. HemoStyp® will be featured in a fall back to school promotion. School Health supplies over 60,000 schools across the country. School Health has evolved from a specialized distributor of basic supplies to a consultative solutions provider for major health initiatives including vision and hearing screening, emergency response preparedness, infection control, and wellness plans. 

In addition, they own and operate Sports Health, a division of School Health that provides products for the sports medicine arena. Douglas Beplate, CEO of United Health Products Inc., added, "We are very pleased to be working within the School Health network and to provide our HemoStyp® to school nurses, sports team trainers, security staff, and emergency personnel throughout the nation to address trauma and wound incidents."

About School Health

School Health Corporation (www.schoolhealth.com) is the leading supplier of health supplies and equipment to schools. More than 95% of the top 500 school districts and largest universities in the United States purchase their products from the company annually. School Health offers customers more than 20,000 products from over 600 manufacturers. This third-generation, family-owned, business was founded in 1957 and currently employs more than 100 people.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

For Investor Relations:
PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

For Media Relations:
Sean Leous, Managing Director 
+1 646.863-8998

United Health Products Engages Maxim Group LLC As Corporate Finance Advisor

Henderson, NV -  July 21, 2015 - United Health Products, Inc. (OTCQB: UEEC) developer, manufacturer and marketer of patented hemostatic gauze for the dental, healthcare, veterinary and wound care sectors, today announced  that the Company has engaged Maxim Group LLC, as its new corporate finance advisor.  Maxim Group, a leading full-service investment bank, securities and wealth management firm, will assist the Company in determining near term growth strategies to execute their business plan. 

Douglas Beplate, Chief Executive Officer of United Health Products, commented, “We are excited to begin working with Maxim.  They have assembled a solid team of knowledgeable and experienced industry professionals that we believe will be critical in moving the Company forward in its mission to develop quality, user-friendly and reliable products for the wound care and retail  markets.  As our Company continues to evolve, having a partner like Maxim Group will help us expand our business and deliver on our overall strategic plan.”

About Maxim Group LLC

Maxim Group LLC is a leading full-service investment banking, securities and wealth management firm headquartered in New York.  The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed income and derivative sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals.  Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA), Securities Insurance Protection Corporation (SIPC), NASDAQ Stock Market and NYSE Arca, Inc.  To learn more about Maxim Group, visit www.maximgrp.com.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

For Investor Relations:
PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

For Media Relations:
Sean Leous, Managing Director 
+1 646.863-8998


United Health Products Inc. Announces Laboratory Test Results

Henderson, NV -  April 7, 2015 - United Health Products, Inc. (OTCQB: UEEC) has received the final laboratory test results and pathology reports for recent porcine testing. The laboratory tests were performed at Mount Sterling Laboratories, and the autopsy and pathology performed at the Utah Veterinary Diagnostic Laboratory, Utah State University.

The test protocol was designed to determine the length of time required to achieve hemostasis on a lateral femoral artery cut in pigs. Hemostasis is a process which causes bleeding to stop. As part of the protocol, the HemoStyp® gauze was placed on the wound site and upon achieving hemostasis, the product was left on the wound site without any sutures, bands, clamps, etc. The wound site was then closed with another strip of HemoStyp® that was placed just under the skin

.Complete hemostasis was achieved within 25 minutes on the incision of the femoral artery. Upon completion of the test, with the HemoStyp® gauze remaining in the cavity, the pigs were placed in an enclosure and allowed to recover. Ten hours after the procedures, two of the three pigs were up and walking, the third pig did not naturally recover. The two pigs were penned and monitored for three weeks eating and gaining weight as they resumed an active life. After three weeks, the pigs were euthanized and autopsied.

The autopsy results determined that there was no trace of HemoStyp® product or residue of the product in the body or any of the organs. Douglas Beplate, CEO said, "The results are remarkable in that they not only show that HemoStyp® is effective at rapid hemostasis in a wound site, but prove it is totally absorbable into the body." He added, "In my opinion HemoStyp® promotes vascular genesis and healing."

The tests reports were furnished to the U.S. Military will be posted for viewing on the United Health Products Inc. website.

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444

PCG Advisory Group, LLC
Kirin Smith, Managing Director
+1-646-863-6519
ksmith@pcgadvisory.com
www.pcgadvisory.com

Media Contact:
Sean Leous
Chief Communications Officer
PCG Advisory Group
D: 646.863-8998
www.pcgadvisory.com


United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor

Henderson, NV -  March 17, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or preparation. Sales generated from this contract are a minimum of three million dollars for year 1 and expected to gross over 20 million dollars in sales during the life of the contract. 

About TRI

TRI began as a small family owned business in 1991 and has since grown over 17 times to become one of the leading manufacturers of first aid and emergency survival products. TRI is located in Los Angeles County California that conducts operations on a 7 acre site with 5 Buildings totaling over 120,000 sq. feet. TRI clients include Walmart, Sam's Club, Target, Walgreens, Nissan and Hyundai to name a few. TRI's management team brings experienced professionals in the areas of Marketing, Design, Information Systems, Production and Executive Management. TRI has been providing product to the country's top retailers for over 20 years. TRI's mission is to be the most dependable and innovative manufacture of First Aid Kits and Emergency Preparedness kits in all categories of Home, Office, School, Auto, Sporting goods, Outdoors, Marina and Farm for the purpose of spreading the Good News and supporting Ministries and Missionaries of all nations.
www.totalresourcesintl.com

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444



United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor

Henderson, NV -  March 17, 2015 - United Health Products, Inc. (OTCQB: UEEC)) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or preparation. Sales generated from this contract are a minimum of three million dollars for year 1 and expected to gross over 20 million dollars in sales during the life of the contract. 

About TRI

TRI began as a small family owned business in 1991 and has since grown over 17 times to become one of the leading manufacturers of first aid and emergency survival products. TRI is located in Los Angeles County California that conducts operations on a 7 acre site with 5 Buildings totaling over 120,000 sq. feet. TRI clients include Walmart, Sam's Club, Target, Walgreens, Nissan and Hyundai to name a few. TRI's management team brings experienced professionals in the areas of Marketing, Design, Information Systems, Production and Executive Management. TRI has been providing product to the country's top retailers for over 20 years. TRI's mission is to be the most dependable and innovative manufacture of First Aid Kits and Emergency Preparedness kits in all categories of Home, Office, School, Auto, Sporting goods, Outdoors, Marina and Farm for the purpose of spreading the Good News and supporting Ministries and Missionaries of all nations.
www.totalresourcesintl.com

About United Health Products Inc.

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Contact:

United Health Products, Inc.
877-358-3444